Madjid Momeni-Moghaddam

Madjid Momeni-Moghaddam

Auto-generated profile, based on publicly available information

Madjid Momeni-Moghaddam

Department of Biology, Faculty of Science, Hakim Sabzevari University, Sabzevar, Iran

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2019 in The International Journal of Lower Extremity Wounds
Verified
Journal Article
Closed access
PDF file
FRFahimeh Rezaie
Fahimeh Rezaie
MMMadjid Momeni-Moghaddam
Madjid Momeni-Moghaddam
HNHojjat Naderi-Meshkin
Hojjat Naderi-Meshkin
Skin as a mechanical barrier between the inner and outer environment of our body protects us against infection and electrolyte loss. This organ consists of 3 layers: the epidermis, dermis, and hypodermis. Any disruption in the integrity of skin leads to the formation of wounds, which are divided into 2 main categories: acute wounds and chronic wounds. Generally, acute wounds heal relatively faster. In contrast to acute wounds, closure of chronic wounds is delayed by 3 months after the initial insult. Treatment of chronic wounds has been one of the most challenging issues in the field of regenerative medicine, promoting scientists to develop various therapeutic strategies for a fast, qualified, and most cost-effective treatment modality. Here, we reviewed more recent approaches, including the development of stem cell therapy, tissue-engineered skin substitutes, and skin equivalents, for the healing of complex wounds.

30 April 2019 in The International Journal of Lower Extremity Wounds
Verified
Journal Article
Closed access
PDF file
HSHamid Reza Shojania
Hamid Reza Shojania
MMMadjid Momeni-Moghaddam
Madjid Momeni-Moghaddam
SHSeyed-Ebrahim. Hossini
Seyed-Ebrahim. Hossini
MAMohammad Armin
Mohammad Armin
JBJalal Omrani Bidi
Jalal Omrani Bidi
This study focused on potential of vitamin C loaded human serum albumin (HSA) nanoparticles for treatment of wound. Nanocarrier were prepared and assessed for their effect on growth of 3T3 fibroblast cells, cell migration, wound healing rate and expression of miR-155, TGF-β1 and SMAD 1,2 genes. Wound healing assay was done and wounds were treated with vitamin C loaded HSA nanoparticles. Nanoparticles were prepared with size and zeta potential of 180±6 and -29 mV, respectively. Vitamin C loaded HSA nanoparticles showed controlled release of vitamin C into the buffer solution. Also, yield and encapsulation efficacy of loaded nanoparticles were obtained as 70.6 and 52.1 %, respectively. MTT results showed that the growth of 3T3 fibroblast cells was promoted in culture medium with 20 µg/ml of vitamin C loaded HSA nanoparticles. Cell migration assay indicated the positive effect of loaded nanoparticles on wound healing. The in-vivo results showed that the rate of wound healing was increased after treatment with 20 µg/ml of vitamin C loaded HSA nanoparticles. The wounds were healed faster when treated with vitamin C loaded HSA nanoparticles in comparison with control group. The expression of miR-155 was downregulated after treatment. Furthermore, expression of TGF-β1 and SMAD 1,2 were increased while the wounds were treated with these nanoparticles. In conclusion, these results showed for the first time that wounds were healed after treatment with albumin nanocarrier loaded with vitamin C. This nanocarrier changed expression of miR-155 and TGF-β1 towards faster healing of wounds.

21 November 2013 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
MMMadjid Momeni-Moghaddam
Madjid Momeni-Moghaddam
MMMaryam M. Matin
Maryam M. Matin
SBSohrab Boozarpour
Sohrab Boozarpour
SSSajjad Sisakhtnezhad
Sajjad Sisakhtnezhad
HMHossein Kazemi Mehrjerdi
Hossein Kazemi Mehrjerdi
ABAhmad Reza Bahrami
Ahmad Reza Bahrami

14 April 2023 in Acta Histochemica
Verified
Journal Article
Closed access
VMVahid Moghimi
Vahid Moghimi
JRJeiran Rahvarian
Jeiran Rahvarian
ZEZohreh Esmaeilzadeh
Zohreh Esmaeilzadeh
NMNajmeh Mohammad-Pour
Najmeh Mohammad-Pour
DBDanial Babaki
Danial Babaki
HNHojjat Naderi-Meshkin
Hojjat Naderi-Meshkin

1 December 2018
Verified
Journal Article
Open access
MKMaryam Kaihanfar
Maryam Kaihanfar
MMMadjid Momeni-Moghaddam
Madjid Momeni-Moghaddam
MMMohammad Javad Mehdipour Moghaddam
Mohammad Javad Mehdipour Moghaddam
THToktam Hajar
Toktam Hajar
VPVahab Dast Pak
Vahab Dast Pak
JBJalal Omrani Bidi
Jalal Omrani Bidi
Background and Objectives: Larval therapy refers to the use of Lucilia sericata larvae on chronic wounds, which is a successful method of chronic wounds treatment. The secretions of these larvae contain antibacterial compounds and lead to death or inhibition of bacterial growth. Materials and Methods: In this study, we investigated the antibacterial effects of Lucilia sericata larvae secretions which were in sterilized and multi antibiotic-resistant bacteria-treated forms on Gram-positive Bacillus subtilis bacteria and Gram-negative Escherichia coli bacteria. In the following, we evaluated changes in gene expression of lucifensin and attacin during treatment with multi antibiotic-resistant bacteria. Investigation of the antibacterial effect was carried out using optical absorption and antibiotic disk diffusion in order to study the expression of the aforementioned genes. Results: The results of this study showed that E. coli-treated larvae were able to inhibit the growth of E. coli and secretions of B. subtilis-treated larvae and were also able to inhibit the growth of B. subtilis. Gene expression of antibacterial peptides in multi antibiotic-resistant bacteria-treated larvae was increased in comparison to non-treated larvae. Conclusion: Due to the significant antibacterial potency of bacteria-treated larvae secretions, the secretions can be a suitable candidate as a drug against antibiotic resistant bacteria, but additional tests are required. Since the antimicrobial peptides of insects have not yet produced any resistance in human pathogenic bacteria, they can be considered as a promising strategy for dealing with resistant infections.